IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
IDEXX LABORATORIES INC /DE cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $338,412,000.00Depreciation and amortization → Operating adjustments reconciliation: $41,051,000.00Share-based compensation expense → Operating adjustments reconciliation: $16,088,000.00Deferred income taxes → Operating adjustments reconciliation: $6,538,000.00Provision for credit losses → Operating adjustments reconciliation: $2,332,000.00Operating adjustments reconciliation → Net cash from operating activities: $8,750,000.00Operating adjustments reconciliation → Accounts receivable: $26,036,000.00Operating adjustments reconciliation → Other assets and liabilities: $20,142,000.00Operating adjustments reconciliation → Accounts payable: $6,736,000.00Operating adjustments reconciliation → Inventories: $4,026,000.00Operating adjustments reconciliation → Other: $319,000.00Proceeds from net investment hedges → investing reconciliation: $1,042,000.00investing reconciliation → Purchases of property and equipment: $24,646,000.00investing reconciliation → Acquisition of intangible assets: $1,892,000.00Net cash used in financing activities → financing reconciliation: $325,189,000.00Proceeds from exercises of stock options and employee stock purchase plans → financing reconciliation: $32,913,000.00financing reconciliation → Repurchases of common stock, including excise tax settlements: $346,804,000.00financing reconciliation → Borrowings (payments) on revolving credit facility, net: $11,000,000.00financing reconciliation → Shares withheld for statutory tax withholding payments on restricted stock: $298,000.00Net cash used in investing activities → investing reconciliation: $25,496,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $200,528,000.00Net cash from operating activities → Cash sources and uses: $347,162,000.00Cash sources and uses → Exchange-rate effect: $72,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $196,933,000.00Cash sources and uses → Net cash used in investing activities: $25,496,000.00Cash sources and uses → Net cash used in financing activities: $325,189,000.00Depreciation and amortization: $41,051,000.00Depreciation & amortization+$41.05 MImpairment charge: $0.00Provision for credit losses: $2,332,000.00Loan & lease loss provision+$2.33 MDeferred income taxes: $6,538,000.00Deferred taxes & credits+$6.54 MShare-based compensation expense: $16,088,000.00Stock-based compensation+$16.09 MOther: -$319,000.00Other operating, net−$319.00 KAccounts payable: -$6,736,000.00Accounts payable−$6.74 MNet income: $338,412,000.00Net income+$338.41 MAccounts receivable: -$26,036,000.00Accounts receivable−$26.04 MInventories: -$4,026,000.00Inventories−$4.03 MOther assets and liabilities: -$20,142,000.00Other working capital, net−$20.14 MNet cash from operating activities: $347,162,000.00Operating cash+$347.16 MOperating adjustments reconciliation: $66,009,000.00Borrowings (payments) on revolving credit facility, net: -$11,000,000.00Credit lines, net−$11.00 MPayments of senior notes: $0.00Repurchases of common stock, including excise tax settlements: -$346,804,000.00Common stock repurchases−$346.80 MProceeds from exercises of stock options and employee stock purchase plans: $32,913,000.00Employee stock plans & options+$32.91 MShares withheld for statutory tax withholding payments on restricted stock: -$298,000.00Stock-award tax withholding−$298.00 KNet cash used in financing activities: -$325,189,000.00. Cash required to fund net payments.Financing cash−$325.19 Mfinancing reconciliation: $358,102,000.00Purchases of property and equipment: -$24,646,000.00PP&E purchases−$24.65 MProceeds from net investment hedges: $1,042,000.00Investing hedge proceeds+$1.04 MEquity investments: $0.00Acquisition of intangible assets: -$1,892,000.00Intangible asset purchases−$1.89 MNet cash used in investing activities: -$25,496,000.00. Cash required to fund net payments.Investing cash−$25.50 Minvesting reconciliation: $26,538,000.00Cash sources and uses: $547,690,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $200,528,000.00Beginning cash$200.53 MEnding cash: Cash, cash equivalents, and restricted cash: $196,933,000.00Ending cash$196.93 MExchange-rate effect: -$72,000.00FX effect−$72.00 KCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$322.52 MOperating cash − cash spent on PP&ECash flow / Net income1.03×Operating cash flow ÷ net incomeNet cash change−$3.60 MEnding cash − beginning cash
Chart details

IDEXX LABORATORIES INC /DE cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
200,528,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
347,162,000 US dollars. Net cash provided.
Net income
338,412,000 US dollars
Depreciation and amortization
41,051,000 US dollars
Impairment charge
0 US dollars
Provision for credit losses
2,332,000 US dollars
Deferred income taxes
6,538,000 US dollars
Share-based compensation expense
16,088,000 US dollars
Other
negative 319,000 US dollars
Accounts payable
negative 6,736,000 US dollars
Accounts receivable
negative 26,036,000 US dollars
Inventories
negative 4,026,000 US dollars
Other assets and liabilities
negative 20,142,000 US dollars
Investing activities
negative 25,496,000 US dollars. Net cash used.
Purchases of property and equipment
negative 24,646,000 US dollars
Proceeds from net investment hedges
1,042,000 US dollars
Equity investments
0 US dollars
Acquisition of intangible assets
negative 1,892,000 US dollars
Financing activities
negative 325,189,000 US dollars. Net cash used.
Borrowings (payments) on revolving credit facility, net
negative 11,000,000 US dollars
Payments of senior notes
0 US dollars
Repurchases of common stock, including excise tax settlements
negative 346,804,000 US dollars
Proceeds from exercises of stock options and employee stock purchase plans
32,913,000 US dollars
Shares withheld for statutory tax withholding payments on restricted stock
negative 298,000 US dollars
Operating adjustment reconciliation
66,009,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
358,102,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
26,538,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 72,000 US dollars
Ending cash on Jun 30, 2026
196,933,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
547,690,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 3,595,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.03×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
347,162,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
24,646,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
322,516,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $8.75M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 347,162,000 US dollars minus 24,646,000 US dollars equals 322,516,000 US dollars.
IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!